Nazarov AA - Search Results

1

Microstructure changes in ultrafine-grained nickel processed by high pressure torsion under ultrasonic treatment.

Samigullina AA, Mukhametgalina AA, Sergeyev SN, Zhilyaev AP, Nazarov AA, Zagidullina YR, Parkhimovich NY, Rubanik VV, Tsarenko YV. Samigullina AA, et al. Among authors: nazarov aa. Ultrasonics. 2018 Jan;82:313-321. doi: 10.1016/j.ultras.2017.09.005. Epub 2017 Sep 15. Ultrasonics. 2018. PMID: 28942271

2

Drift of dislocation tripoles under ultrasound influence.

Murzaev RT, Bachurin DV, Nazarov AA. Murzaev RT, et al. Among authors: nazarov aa. Ultrasonics. 2016 Jan;64:77-82. doi: 10.1016/j.ultras.2015.08.001. Epub 2015 Aug 6. Ultrasonics. 2016. PMID: 26278625

3

Discrete dislocation simulation of the ultrasonic relaxation of non-equilibrium grain boundaries in a deformed polycrystal.

Bachurin DV, Murzaev RT, Nazarov AA. Bachurin DV, et al. Among authors: nazarov aa. Ultrasonics. 2021 Dec;117:106555. doi: 10.1016/j.ultras.2021.106555. Epub 2021 Aug 19. Ultrasonics. 2021. PMID: 34455145

4

Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin.

Nosova YN, Zenin IV, Maximova VP, Zhidkova EM, Kirsanov KI, Lesovaya EA, Lobas AA, Gorshkov MV, Kovaleva ON, Milaeva ER, Galanski M, Keppler BK, Nazarov AA. Nosova YN, et al. Among authors: nazarov aa. Bioinorg Chem Appl. 2017;2017:4736321. doi: 10.1155/2017/4736321. Epub 2017 Jul 19. Bioinorg Chem Appl. 2017. PMID: 28804273 Free PMC article.

5

Versatile analytical methodology for evaluation of drug-like properties of potentially multi-targeting anticancer metallodrugs.

Foteeva LS, Nosova YN, Nazarov AA, Keppler BK, Timerbaev AR. Foteeva LS, et al. Among authors: nazarov aa. Anal Sci. 2022 Mar;38(3):627-632. doi: 10.1007/s44211-022-00076-9. Epub 2022 Feb 21. Anal Sci. 2022. PMID: 35286638

6

Understanding the interactions of diruthenium anticancer agents with amino acids.

Nazarov AA, Mendoza-Ferri MG, Hanif M, Keppler BK, Dyson PJ, Hartinger CG. Nazarov AA, et al. J Biol Inorg Chem. 2018 Oct;23(7):1159-1164. doi: 10.1007/s00775-018-1597-x. Epub 2018 Jul 25. J Biol Inorg Chem. 2018. PMID: 30046902

7

Ru(III) Complexes with Lonidamine-Modified Ligands.

Shutkov IA, Okulova YN, Tyurin VY, Sokolova EV, Babkov DA, Spasov AA, Gracheva YA, Schmidt C, Kirsanov KI, Shtil AA, Redkozubova OM, Shevtsova EF, Milaeva ER, Ott I, Nazarov AA. Shutkov IA, et al. Among authors: nazarov aa. Int J Mol Sci. 2021 Dec 15;22(24):13468. doi: 10.3390/ijms222413468. Int J Mol Sci. 2021. PMID: 34948263 Free PMC article.

8

Is antitumor Pt(IV) complex containing two axial lonidamine ligands a true dual- or multi-action prodrug?

Kasparkova J, Kostrhunova H, Novohradsky V, Ma L, Zhu G, Milaeva ER, Shtill AA, Vinck R, Gasser G, Brabec V, Nazarov AA. Kasparkova J, et al. Among authors: nazarov aa. Metallomics. 2022 Jul 20;14(7):mfac048. doi: 10.1093/mtomcs/mfac048. Metallomics. 2022. PMID: 35759404

9

Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives.

Habala L, Galanski MS, Yasemi A, Nazarov AA, von Keyserlingk NG, Keppler BK. Habala L, et al. Among authors: nazarov aa. Eur J Med Chem. 2005 Nov;40(11):1149-55. doi: 10.1016/j.ejmech.2005.06.003. Epub 2005 Jul 22. Eur J Med Chem. 2005. PMID: 16040163

10

A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?

Berger I, Nazarov AA, Hartinger CG, Groessl M, Valiahdi SM, Jakupec MA, Keppler BK. Berger I, et al. Among authors: nazarov aa. ChemMedChem. 2007 Apr;2(4):505-14. doi: 10.1002/cmdc.200600279. ChemMedChem. 2007. PMID: 17340670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page